(Q35308393)

7 August 2017

title

Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma (English)

1 reference

7 August 2017

D Balicki

1

1 reference

7 August 2017

R A Reisfeld

2

1 reference

7 August 2017

U Pertl

3

1 reference

7 August 2017

E Beutler

4

1 reference

7 August 2017

H N Lode

5

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Proceedings of the National Academy of Sciences of the United States of America

7 August 2017

published in

1 reference

7 August 2017

volume

97

1 reference

7 August 2017

issue

21

1 reference

7 August 2017

page(s)

11500-11504

1 reference

Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

Histone H2A significantly enhances in vitro DNA transfection.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrow

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

Gene therapy for cancer: what have we done and where are we going?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=17229

12 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.210382997

Induced immunity by expression of interleukin-2 or GM-CSF gene in murine neuroblastoma cells can generate antitumor response to established tumors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.210382997

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11016973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Natural killer cell-mediated eradication of neuroblastoma metastases to bone marrow by targeted interleukin-2 therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/11016973

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.210382997

1 reference

7 August 2017

0 references

1 reference

7 August 2017

1 reference